Intra Cellular Therapies shares owned by Bellevue Group
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Bellevue Group
from 13F filings
Historical chart of Bellevue Group investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intra Cellular Therapies by Bellevue Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $220M | 3.1M | 71.62 |
| 2023-09-30 | $165M | 3.2M | 52.09 |
| 2023-06-30 | $203M | 3.2M | 63.32 |
| 2023-03-31 | $177M | 3.3M | 54.15 |
| 2022-12-31 | $177M | 3.3M | 52.92 |
| 2022-09-30 | $155M | 3.3M | 46.53 |
| 2022-06-30 | $191M | 3.3M | 57.08 |
| 2022-03-31 | $210M | 3.4M | 61.19 |
| 2021-12-31 | $190M | 3.6M | 52.34 |
| 2021-09-30 | $141M | 3.8M | 37.28 |
| 2021-06-30 | $147M | 3.6M | 40.82 |
| 2021-03-31 | $124M | 3.7M | 33.93 |
| 2020-12-31 | $116M | 3.7M | 31.80 |
| 2020-09-30 | $92M | 3.6M | 25.66 |
| 2020-06-30 | $97M | 3.8M | 25.67 |
| 2020-03-31 | $57M | 3.7M | 15.37 |
| 2019-12-31 | $81M | 2.4M | 34.30 |
| 2019-09-30 | $19M | 2.6M | 7.47 |
| 2019-06-30 | $29M | 2.2M | 12.99 |
| 2018-12-31 | $599k | 53k | 11.39 |
| 2018-09-30 | $1.2M | 55k | 21.70 |
| 2018-06-30 | $1.4M | 80k | 17.67 |
| 2018-03-31 | $1.9M | 91k | 21.05 |
| 2017-12-31 | $1.3M | 93k | 14.48 |
| 2017-09-30 | $631k | 40k | 15.78 |
| 2017-06-30 | $497k | 40k | 12.42 |